Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2006-11-21
2006-11-21
Weber, Jon (Department: 1653)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C530S350000, C435S007100, C435S068100
Reexamination Certificate
active
07138255
ABSTRACT:
Compositions and methods for the isolation and manipulation of misfolded, or partially misfolded, proteins present in blood and other biological materials are provided. In one aspect of the invention, the compositions, hereinafter termed “proteons” are comprised of misfolded proteins. Also provided are compositions and methods for the isolation and manipulation of proteon nucleation centers (PNCs) upon which the proteons of the present in blood and other biological materials form. In another aspect of the invention, the PNCs are comprised of metallic nanoclusters.
REFERENCES:
patent: 5874238 (1999-02-01), Potempa et al.
patent: WO 02/073210 (2002-09-01), None
Otvos JD, Armitage IM., Structure of the metal clusters in rabbit liver metallothionein., Proc Natl Acad Sci U S A. Dec. 1980;77(12):7094-8.
Watanabe et al., Inhibition against heat coagulation of ovotransferrin by ovalbumin dry-heated at 120 degrees C.J Agric Food Chem. Sep. 2000;48(9):3965-72.
Aguzzi, A., “Prion diseases, blood and the immune system: concerns and reality,”Haematologica, Jan. 2000, pp. 3-10, vol. 85, No. 1.
Aguzzi, A., “Blood simple prion diagnostics,”Nature Medicine, Mar. 2001, pp. 289-290, vol. 7, No. 3.
Aiken III, J. D. & Finke, R. G, “A review of modern transition-metal nanoclusters: their synthesis, characterization, and applications in catalysis,”Journal of Molecular Catalysis A: Chemical, 1999, pp. 1-44, vol. 145.
Attwood, T. K., “Metals in prion disease,”Trends in Biotechnology, Jun. 2002, p. 235, vol. 20, No. 6.
Brown, P., et al., “Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease,”J. Lab. Clin. Med., 2001, pp. 5-13, vol. 137.
Bush, A.I., “Metals and neuroscience,”Current Opinions in Chemical Biology, 2000, pp. 184-191, vol. 4.
Bush, A. I., et al., “Rapid induction of Alzheimer A beta amyloid formation by zinc,”Science, Sep. 1994, pp. 1464-1467, vol. 265, No. 5177.
Bush, A. I., “Metal complexing agents as therapies for Alzheimer's disease,”Neurobiology of Aging, 2002, pp. 1031-1038, vol. 23.
Campbell, A., et al., “Mechanisms by which metals promote events connected to neurodegenerative disease,”Brain Research Bulletin, 2001, pp. 125-132, vol. 55, No. 2.
Carrel, R.W., & Lomas, D.A., “Conformational disease,”Lancet, Jul. 12, 1997, pp. 134-138, vol. 350.
Gerner, C., “Biochemische Analyse endobiontischer Strukturen aus dem menshlichen Blut,” [“Biochemical Analysis of Endobiontic Structures from Human Blood”]Curriculum Oncologicum01, Jan. 7, 1997.
Harper, J. D. & Lansbury, P. T., Jr., “Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins,”Ann. Rev. Biochem., 1997, pp. 385-407, vol. 66.
Lehmann, S., “Metal ions and prion diseases,”Current Opinion in Chemical Biology, 2002, pp. 187-192, vol. 6.
Liu, C. & Xu, H., “The metal site as a template for the metalloprotein structure formation,”Journal of Inorganic Biochemistry, 2002, pp. 77-86, vol. 88.
Rhodes, E., et al.,“Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide,”Biochemica et Biophysica Acta, 2000, pp. 230-238, vol. 1476.
Saborio, G. P., et al., “Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding,”Nature, Jun. 14, 2001, pp. 810-813, vol. 411.
Soto, C., et al., “Cyclic amplification of protein misfolding: application to prion-related disorders and beyond,”Trends in Neurosciences, Aug. 2002, pp. 390-394, vol. 25, No. 8.
Thackray, A. M., et al., “Metal imbalance and compromised antioxidant function are early changes in prion disease,”Biochem. J., 2002, pp. 253-258, vol. 362.
Pustovyy Oleg M.
Samoylov Alexandre M.
Vodyanoy Vitaly J.
Andrus Sceales, Starke & Sawall
Auburn University
Mondesi Robert B.
Weber Jon
LandOfFree
Method of isolation and self-assembly of small protein... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of isolation and self-assembly of small protein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of isolation and self-assembly of small protein... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3644822